ATE155477T1 - Gangliosideanaloge - Google Patents

Gangliosideanaloge

Info

Publication number
ATE155477T1
ATE155477T1 AT92923719T AT92923719T ATE155477T1 AT E155477 T1 ATE155477 T1 AT E155477T1 AT 92923719 T AT92923719 T AT 92923719T AT 92923719 T AT92923719 T AT 92923719T AT E155477 T1 ATE155477 T1 AT E155477T1
Authority
AT
Austria
Prior art keywords
group
bond
pct
together form
formula
Prior art date
Application number
AT92923719T
Other languages
English (en)
Inventor
Hans Goeran Magnusson
Kumar Ray Asim
Original Assignee
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK911853A external-priority patent/DK185391D0/da
Priority claimed from DK88092A external-priority patent/DK88092D0/da
Application filed by Symbicom Ab filed Critical Symbicom Ab
Application granted granted Critical
Publication of ATE155477T1 publication Critical patent/ATE155477T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92923719T 1991-11-11 1992-11-11 Gangliosideanaloge ATE155477T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK911853A DK185391D0 (da) 1991-11-11 1991-11-11 Carbonhydratderivater
DK88092A DK88092D0 (da) 1992-07-03 1992-07-03 Carbonhydratderivater

Publications (1)

Publication Number Publication Date
ATE155477T1 true ATE155477T1 (de) 1997-08-15

Family

ID=26064834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92923719T ATE155477T1 (de) 1991-11-11 1992-11-11 Gangliosideanaloge

Country Status (8)

Country Link
US (1) US5637569A (de)
EP (1) EP0642523B1 (de)
JP (1) JPH07504884A (de)
AT (1) ATE155477T1 (de)
AU (1) AU674293B2 (de)
CA (1) CA2123213A1 (de)
DE (1) DE69220970D1 (de)
WO (1) WO1993010134A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3930559B2 (ja) * 1994-07-15 2007-06-13 太陽化学株式会社 シアル酸誘導体を含有する医薬組成物
ES2303337T3 (es) 1995-01-20 2008-08-01 G.D. Searle Llc Inhibidores de la proteasa retroviral de bis-hidroxietilamino sulfonamida.
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
ATE479425T1 (de) 1998-04-10 2010-09-15 Mitsubishi Chem Corp Sialsäure-derivate enthaltende feste dispersion
US6761816B1 (en) * 1998-06-23 2004-07-13 Clinical Micro Systems, Inc. Printed circuit boards with monolayers and capture ligands
US6245902B1 (en) * 1999-08-09 2001-06-12 University Of Iowa Research Foundation C-glycoside analogs and methods for their preparation and use
US20040058407A1 (en) * 2001-04-10 2004-03-25 Miller Scott E. Reactor systems having a light-interacting component
EP1409712A4 (de) * 2001-04-10 2008-05-14 Bioprocessors Corp Mikrofermentervorrichtung und screeningverfahren auf zellbasis
CA2793276A1 (en) * 2009-03-27 2010-09-30 Zacharon Pharmaceuticals, Inc. Ganglioside biosynthesis modulators
AR093275A1 (es) * 2010-03-17 2015-05-27 Centro De Excelencia En Productos Y Procesos De Cordoba (Ceprocor) Una composicion farmaceutica soluble en agua que comprende al menos una sustancia terapeuticamente activa de caracteristicas hidrofobicas y al menos un compuesto seleccionado entre los sialoglicoesfingolipidos, los glicoesfingolipidos o una mezcla de sialoglicoesfingolipidos y glicoesfingolipidos
CA2865627C (en) * 2012-03-16 2021-01-19 Robert J. Woods Glycomimetics to inhibit pathogen-host interactions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation

Also Published As

Publication number Publication date
DE69220970D1 (en) 1997-08-21
AU674293B2 (en) 1996-12-19
US5637569A (en) 1997-06-10
EP0642523B1 (de) 1997-07-16
WO1993010134A1 (en) 1993-05-27
JPH07504884A (ja) 1995-06-01
AU2942892A (en) 1993-06-15
CA2123213A1 (en) 1993-05-27
EP0642523A1 (de) 1995-03-15

Similar Documents

Publication Publication Date Title
ATE155477T1 (de) Gangliosideanaloge
DK0405864T3 (da) Phospholipase A2-inhibitor, mikroorganismer der producerer inhibitoren og fremgangsmåder til den fremstilling
FI98460B (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
DE69615444D1 (de) Hyperverzweigte Polyaspartatester und Verfahren zu ihrer Herstellung
ES2124883T3 (es) Compuestos antiviricos.
DE3584158D1 (de) Prostaglandinanaloge, verfahren zu ihrer herstellung und ihre pharmazeutischen zusammenstellungen.
EP4308168A1 (de) Verfahren zur herstellung von cyclooctenen und konjugaten davon
UA41296C2 (uk) Складні ефіри нуклеозиду та його похідні, фармацевтична композиція на їх основі
DE3576952D1 (de) Verfahren zur herstellung von 4-phenyl-pyrrol-derivaten.
HUT56557A (en) Process for producing oxetanone derivatives and pharmaceutical compositions comprising same as active ingredient
MY118074A (en) Soap bar composition.
HK1003785A1 (en) Mono esters of dicarboxylic acids their preparation and use
ATE42545T1 (de) Imidazolide, verfahren zu deren herstellung und deren anwendung als zwischenprodukte in der synthese von cytotoxischen nebenprodukten.
DK0738258T3 (da) Fremgangsmåde til fremstilling af N-substituerede glycinsyrer eller glycinestere og anvendelse af fremgangsmåden til indigo
GB1514389A (en) Glycerides with antibacterial properties
IE872578L (en) Antigestagen compositions
AR004682A1 (es) Compuestos acidos fosfinicos sustituidos, metodos para prepararlos, metodos para preparar compuestos intermediarios, composicion farmaceutica y suaplicacion como medicamentos.
MX9804752A (es) Conjugados covalentes de lipidos-acidos fosfonocarboxilicos, la produccion de los mismos asi como su uso como agentes farmaceuticos antivirales .
EG18643A (en) Pharmaceutical compositions containing trapidil,a process for the preparation thereof and related therapeutic use
FR2485000B1 (de)
KR870008888A (ko) 디하이드로-1h-피롤리진-3,5-(2h,6h)-디온을 제조하는 개선된 방법
DE69207030D1 (de) Terpenderivate und Verfahren zu ihrer Herstellung
GR3001818T3 (en) Process for the preparation of optically active carbacyclin intermediates
JPS5598200A (en) Preparation of 24xi, 25-dihydroxycholesta-1,4,6-trien-3-one
DE3683073D1 (de) 3-oxo-2-azabicyclohexan-derivate, verfahren zu ihrer herstellung und verwendung dieser derivate als zwischenverbindungen fuer antibakterielle wirkstoffe.